Kenton, United Kingdom

Daryl David Rees

This inventor holds 2 USPTO granted patents. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daryl David Rees. Retrieved from https://idiyas.com/inventor/daryl-david-rees-flv8rfpr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Daryl David Rees

Introduction

Daryl David Rees, a notable inventor based in Keston, GB, has made significant contributions to the field of medical science through his inventive work. With two patents to his name, Rees has established a reputation for developing innovative solutions that address critical health issues.

Latest Patents

Among his notable inventions, Daryl Rees is recognized for his work on nitric oxide synthase inhibitors. These patents contribute to the understanding and treatment of various health conditions, showcasing Rees's commitment to advancing medical research and therapeutic options.

Career Highlights

Throughout his career, Rees has worked with prominent organizations, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His tenure at these esteemed companies has allowed him to collaborate with leading experts in the pharmaceutical industry and further develop his innovative ideas.

Collaborations

Daryl's work has been enriched by collaborations with talented individuals such as Richard Mansfield Beams and Martin James Drysdale. These partnerships have fostered a creative environment that drives innovation and contributes to the development of new therapeutic approaches.

Conclusion

With his patents and extensive experience in the pharmaceutical industry, Daryl David Rees exemplifies the spirit of innovation. His contributions to nitric oxide synthase inhibitors highlight his dedication to improving health outcomes and his ongoing impact on medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…